Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies

E Balboni, F Zagnoli, T Filippini… - Journal of Trace …, 2022 - Elsevier
Background and aim The COVID-19 pandemic has severely affected the world's population
in the last two years. Along with non-pharmacological public health interventions, major …

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

S Copur, M Berkkan, C Basile, K Tuttle, M Kanbay - Journal of nephrology, 2022 - Springer
COVID-19, a disease caused by a novel coronavirus (SARS-CoV-2), is a major global threat
that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives …

Vitamin C supplementation for the treatment of COVID-19: a systematic review and meta-analysis

M Olczak-Pruc, D Swieczkowski, JR Ladny, M Pruc… - Nutrients, 2022 - mdpi.com
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …

COVID-19 in joint ageing and osteoarthritis: current status and perspectives

M Lauwers, M Au, S Yuan, C Wen - International journal of molecular …, 2022 - mdpi.com
COVID-19 is a trending topic worldwide due to its immense impact on society. Recent trends
have shifted from acute effects towards the long-term morbidity of COVID-19. In this review …

An exploratory study of tweets about the SARS-CoV-2 Omicron variant: Insights from sentiment analysis, language interpretation, source tracking, type classification …

N Thakur, CY Han - COVID, 2022 - mdpi.com
This paper presents the findings of an exploratory study on the continuously generating Big
Data on Twitter related to the sharing of information, news, views, opinions, ideas …

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II

M Fathi-Kazerooni, S Fattah-Ghazi, M Darzi… - Stem Cell Research & …, 2022 - Springer
Abstract Background Cell-free Mesenchymal stromal cells (MSCs) have been considered
due to their capacity to modulate the immune system and suppress cytokine storms caused …

Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)

T Khouja, K Mitsantisuk, M Tadrous… - Journal of Antimicrobial …, 2022 - academic.oup.com
Background Little is known about the effect of the COVID-19 pandemic on antimicrobial
consumption worldwide. Objectives To describe the impact of the WHO Global Action Plan …

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

M AlQahtani, N Kumar, D Aljawder, A Abdulrahman… - Scientific Reports, 2022 - nature.com
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …

Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …